Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Agitation in Alzheimer's Disease
NCT02792257Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2017
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in Alzheimer's disease (AD), sponsored by Johns Hopkins University. Started Mar 2017; status: completed.
02
Drugs
dronabinol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02792257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02792257.